• Home
  • The MMS Difference
    • About Us
    • Leadership
    • Certifications
  • Services
    • Regulatory Affairs and Operations
    • Data Management and Biostatistics
    • Regulatory and Medical Writing
    • Drug Safety and Pharmacovigilance
    • Compliance and Transparency
    • Data Sciences
  • Working with MMS
  • News and Media
  • Webinars
  • MMS Blog
  • Careers
  • Contact Us
MMS
MMS HOLDINGS TO DEBUT DATACISE INTEGRATED SAFETY EXPLORER TO DETECT SAFETY SIGNALS USING REAL-WORLD EVIDENCE DURING PHUSE/FDA DATA SCIENCE INNOVATION CHALLENGE

MMS HOLDINGS TO DEBUT DATACISE INTEGRATED SAFETY EXPLORER TO DETECT SAFETY SIGNALS USING REAL-WORLD EVIDENCE DURING PHUSE/FDA DATA SCIENCE INNOVATION CHALLENGE

by Don McLean | Mar 4, 2020 | News

MMS Holdings to Debut Datacise Integrated Safety Explorer to Detect Safety Signals Using Real-World Evidence During PHUSE/FDA Data Science Innovation Challenge CANTON, Mich. (March 4, 2020) – MMS Holdings (MMS) – an award-winning, data-focused CRO – announced today...
Recommended Reading from Eight Pharmaceutical Experts This Summer

Recommended Reading from Eight Pharmaceutical Experts This Summer

by Don McLean | Aug 15, 2019 | Blog

Recommended Reading from Eight Pharmaceutical Experts This Summer by Staff Writer Summer reading isn’t reserved for school-aged children, as adults and professionals alike can gain knowledge and insights from consistently reading material during the hottest months of...
Building a robust clinical data science process

Building a robust clinical data science process

by curtis@digitalliance.com | Jun 7, 2018 | Blog

Building a robust clinical data science process by Staff writer During PhUSE US Connect 2018 – the clinical data science conference – in Raleigh, North Carolina, MMS data science experts presented a paper and corresponding poster, titled Big Data Paradox: Development...

Recent Posts

  • Whitepaper: Pharmaceutical Industry Challenges Facing Clinical Trial Disclosure and Transparency
  • Helping to Accelerate the Search for Solutions to the COVID-19 Crisis
  • IGY Life Sciences Partners with MMS Holdings to Develop Novel COVID-19 Antibody Treatment
  • Pharmaceutical Industry News Roundup: May 2020
  • University of Michigan School of Information Invites MMS Holdings Executive Kelly J. Hill to Join External Advisory Board

Tags

ALZ awareness Alzheimers big data biosimilars biostatistics Clinical Development clinical research clinical study reports clinical trials clinical trial transparency Community Compliance COVID-19 CRO data management data privacy data science drug development EMA ENDALZ FDA Flint GDPR GXP auditing Health Analytics Collective Health Canada Lay summaries leadership medical writing NDA submission opioids pharma pharmacovigilance PhUSE Policy 0070 quality control real world data regulatory operations REMS resourcing statistical programming suicidality transparency trial regulation Volunteering